Your browser doesn't support javascript.
loading
Hyperinsulinemic hypoglycemia in seven patients with de novo NSD1 mutations.
Grand, Katheryn; Gonzalez-Gandolfi, Christina; Ackermann, Amanda M; Aljeaid, Deema; Bedoukian, Emma; Bird, Lynne M; De Leon, Diva D; Diaz, Jullianne; Hopkin, Robert J; Kadakia, Sejal P; Keena, Beth; Klein, Karen O; Krantz, Ian; Leon, Eyby; Lord, Katherine; McDougall, Carey; Medne, Livija; Skraban, Cara M; Stanley, Charles A; Tarpinian, Jennifer; Zackai, Elaine; Deardorff, Matthew A; Kalish, Jennifer M.
Afiliação
  • Grand K; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Gonzalez-Gandolfi C; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Ackermann AM; Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Aljeaid D; Department of Pediatrics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Bedoukian E; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Bird LM; Department of Genetic Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • De Leon DD; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Diaz J; Department of Pediatrics, Division of Genetics, University of San Diego, California and Rady Children's Hospital, San Diego, California.
  • Hopkin RJ; Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Kadakia SP; Department of Pediatrics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Keena B; Rare Disease Institute - Genetics and Metabolism, Children's National Health System, Washington, District of Columbia.
  • Klein KO; Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
  • Krantz I; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Leon E; Department of Pediatrics, Division of Endocrinology, University of San Diego, California and Rady Children's Hospital, San Diego, California.
  • Lord K; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • McDougall C; Department of Pediatrics, Division of Endocrinology, University of San Diego, California and Rady Children's Hospital, San Diego, California.
  • Medne L; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Skraban CM; Department of Pediatrics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Stanley CA; Rare Disease Institute - Genetics and Metabolism, Children's National Health System, Washington, District of Columbia.
  • Tarpinian J; Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Zackai E; Department of Pediatrics, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, Pennsylvania.
  • Deardorff MA; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
  • Kalish JM; Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Am J Med Genet A ; 179(4): 542-551, 2019 04.
Article em En | MEDLINE | ID: mdl-30719864
ABSTRACT
Sotos syndrome is an overgrowth syndrome characterized by distinctive facial features and intellectual disability caused by haploinsufficiency of the NSD1 gene. Genotype-phenotype correlations have been observed, with major anomalies seen more frequently in patients with 5q35 deletions than those with point mutations in NSD1. Though endocrine features have rarely been described, transient hyperinsulinemic hypoglycemia (HI) of the neonatal period has been reported as an uncommon presentation of Sotos syndrome. Eight cases of 5q35 deletions and one patient with an intragenic NSD1 mutation with transient HI have been reported. Here, we describe seven individuals with HI caused by NSD1 gene mutations with three having persistent hyperinsulinemic hypoglycemia. These patients with persistent HI and Sotos syndrome caused by NSD1 mutations, further dispel the hypothesis that HI is due to the deletion of other genes in the deleted 5q35 region. These patients emphasize that NSD1 haploinsufficiency is sufficient to cause HI, and suggest that Sotos syndrome should be considered in patients presenting with neonatal HI. Lastly, these patients help extend the phenotypic spectrum of Sotos syndrome to include HI as a significant feature.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Deficiências do Desenvolvimento / Histona-Lisina N-Metiltransferase / Hiperinsulinismo Congênito / Síndrome de Sotos / Transtornos do Crescimento / Mutação Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Deficiências do Desenvolvimento / Histona-Lisina N-Metiltransferase / Hiperinsulinismo Congênito / Síndrome de Sotos / Transtornos do Crescimento / Mutação Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Infant / Male / Newborn Idioma: En Ano de publicação: 2019 Tipo de documento: Article